✦ LIBER ✦

Histologic improvement following treatment with once weekly pegylated interferon alfa-2a (PEGASYSTM) and thrice weekly interferon alfa-2a (RoferonTM) in patients with chronic hepatitis C without cirrhosis

✍ Scribed by Reddy, K. Rajender; Shiffman, Mitchell; Reindollar, Robert; Fried, Michael; Pockros, Paul; Hoffman, Joseph; DePamphilis, Jean

Book ID: 122465068
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 175 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)85923-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histologic improvement following treatme

Histologic improvement following treatment with once weekly pegylated interferon alfa-2a (pegasysTM) and thrice weekly interferon alfa-2a (roferonTM) in patients with chronic hepatitis C and compensated cirrhosis

✍ Balart, Luis A.; Lee, Samuel S.; Schiffman, Mitchell; Reindollar, Robert; Minuk, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Histological outcome in patients with ch

Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course

✍ Olle Reichard; Hans Glauman; Gunnar Norkrans; Rune Wejstål; Aril Fryden; Robert 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB

260 SUCCESSFUL THERAPY WITH PEGYLATED IN

260 SUCCESSFUL THERAPY WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN CAUSES A SUSTAINED DECREASE IN PORTAL PRESSURE IN PATIENTS WITH CHRONIC HEPATITIS C-RELATED CIRRHOSIS

✍ M. Garcia-Retortillo; D. Rincón; A. Albillos; J. Colmenero; R. Bataller; J.L. Ca 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Acute inflammatory demyelinating polyneu

Acute inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alfa-2a in a patient with chronic hepatitis C virus infection: a case report

✍ Mounia Lahbabi, Meryem Ghissassi, Faouzi Belahcen… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 187 KB

F-7 Insulin resistance does not affect s

F-7 Insulin resistance does not affect sustained virologic response in patients with chronic hepatitis C without cirrhosis treated with peg-interferon alfa 2a and ribavirin

✍ L. Chessa; G. Serra; C. Balestrieri; M. Conti; M. Casale; C. Calabrò; S. Cappell 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Two-year biochemical, virological, and h

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment

✍ Olle Reichard; Hans Glaumann; Aril Frydén; Gunnar Norkrans; Robert Schvarcz; And 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 551 KB

OLLE REICHARD,l HANS GLAUMA",2'3 h I L FRYDEN? GUNNAR NORKRANS,' ROBERT SCHvARCZ,2 ANDERS SONNERBORG,2'6 ZHI-BING YUN,' AND OLA WEILAND2 Fourteen patients with chronic hepatitis C who had a sustained response to a 60-week interferon alfa-2b treatment course were followed, biochemically and virologi